Vestibular Toxicity Due to Inhaled Tobramycin in a Patient With Renal Insufficiency
Authors:
- Randall S. EdsonRERandall S. Edson
- Robert H. BreyRBRobert H. Brey
- Thomas J. McDonaldTMThomas J. McDonald
- Christine L. TerrellCTChristine L. Terrell
- James T. McCarthyJMJames T. McCarthy
- Janet M. ThibertJTJanet M. Thibert
- 30 September 2004
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (9) , 1185-1191
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Toxic Serum Trough Concentrations After Administration of Nebulized TobramycinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Acute renal failure in cystic fibrosis: Association with inhaled tobramycin therapyPediatric Pulmonology, 2002
- Adjunctive Salvage Therapy with Inhaled Aminoglycosides for Patients with Persistent Smear-Positive Pulmonary TuberculosisClinical Infectious Diseases, 2001
- Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Efficacy of Aerosolized Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1993
- Lung Distribution and Pharmacokinetics of Aerosolized TobramycinAmerican Review of Respiratory Disease, 1993
- The Development of the Dizziness Handicap InventoryJAMA Otolaryngology–Head & Neck Surgery, 1990
- Quantitative Deposition of Aerosolized Gentamicin in Cystic FibrosisAmerican Review of Respiratory Disease, 1987
- Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosidesAntimicrobial Agents and Chemotherapy, 1987